Neuromodulation in epilepsy

Neurosurgery

Volumn 69, Issue 4, 2011, Pages 957-979

  Al Otaibi, Faisal A ^a   Hamani, Clement ^b   Lozano, Andres M ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Brain cooling; Deep brain stimulation; Drug delivery; Epilepsy; Gene therapy; Neuromodulation; Neurostimulation

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ADENOSINE; ADENOVIRUS VECTOR; AMINO ACID RECEPTOR BLOCKING AGENT; AMINOTRANSFERASE; ASPARTOACYLASE; BOTULINUM TOXIN; DIAZEPAM; GABA4; GABAPENTIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE RECEPTOR AGONIST; LIDOCAINE; MUSCIMOL; OMEGA CONOTOXIN MVIIA; PENTOBARBITAL; PHENYTOIN; PROTIRELIN; SEROTONIN 1A AGONIST; TAURINE; UNCLASSIFIED DRUG; VALPROIC ACID;

AFTERDISCHARGE; ANTERIOR HYPOTHALAMIC NUCLEUS; APPLICATION SITE PARESTHESIA; ASYMPTOMATIC DISEASE; BRAIN HEMORRHAGE; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CLINICAL EFFECTIVENESS; COMPLEX PARTIAL SEIZURE; COOLING; CORTICAL AMYGDALA; COUGHING; DEPRESSION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; ELECTRODE; ELECTROENCEPHALOGRAPHY; ELECTROSTIMULATION; EPIDURAL HEMATOMA; EPILEPSY; EPILEPTIC STATE; FEASIBILITY STUDY; FOCAL EPILEPSY; GENE TARGETING; GLOSSOPHARYNGEAL NERVE; GRAND MAL EPILEPSY; GRAND MAL SEIZURE; HIPPOCAMPUS; HISTORY OF MEDICINE; HUMAN; INFECTION; LENNOX GASTAUT SYNDROME; LIQUORRHEA; MORBIDITY; MULTICENTER STUDY (TOPIC); NAUSEA; NERVE STIMULATION; NERVE TRANSPLANTATION; NEUROMODULATION; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PURKINJE CELL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SUBTHALAMIC NUCLEUS; SUICIDE; TEMPORAL LOBE EPILEPSY; THALAMUS ANTERIOR NUCLEUS; THALAMUS NUCLEUS; THORAX PAIN; TISSUE TRANSPLANTATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TRIGEMINAL NERVE; UPREGULATION; VAGUS NERVE STIMULATION; VIRAL GENE DELIVERY SYSTEM; WHITE MATTER;

ANIMALS; ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; ELECTRIC STIMULATION THERAPY; EPILEPSY; GENE THERAPY; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 80053652830     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31822b30cd     Document Type: Review

References (380)

1. Cooper IS, Amin I, Gilman S. The effect of chronic cerebellar stimulation upon epilepsy in man. Trans Am Neurol Assoc. 1973;98:192-196.
2. Sramka M, Fritz G, Galanda M, Nadvornik P. Some observations in treatment stimulation of epilepsy. Acta Neurochir (Wien). 1976;(23 suppl):257-262.
3. Ardern S. Cerebellar stimulation for epilepsy. Nurs Times. 1985;81(16):32-34.
4. Vagus nerve stimulation for the control of epilepsy. Proceedings of a symposium held in conjunction with the American Epilepsy Society annual meeting. Boston, Massachusetts, December 2, 1989. Epilepsia. 1990;31(suppl 2):S1-S60.
5. Chkhenkeli SA, Chkhenkeli IS. Effects of therapeutic stimulation of nucleus caudatus on epileptic electrical activity of brain in patients with intractable epilepsy. Stereotact Funct Neurosurg. 1997;69(1-4 pt 2):221-224.
6. Velasco F, Velasco M, Jimenez F, Velasco AL, Marquez I. Stimulation of the central median thalamic nucleus for epilepsy. Stereotact Funct Neurosurg. 2001;77(1-4):228-232.
7. Velasco F, Velasco M, Velasco AL, Menez D, Rocha L. Electrical stimulation for epilepsy: Stimulation of hippocampal foci. Stereotact Funct Neurosurg. 2001;77 (1-4):223-227.
8. Tellez-Zenteno JF, McLachlan RS, Parrent A, Kubu CS,Wiebe S. Hippocampal electrical stimulation in mesial temporal lobe epilepsy. Neurology. 2006;66(10): 1490-1494.
9. Benabid AL, Koudsie A, Benazzouz A, et al. Deep brain stimulation of the corpus luysi (subthalamic nucleus) and other targets in Parkinson's disease. Extension to new indications such as dystonia and epilepsy. J Neurol. 2001;248(suppl 3): III37-III47.
10. Hodaie M, Wennberg RA, Dostrovsky JO, Lozano AM. Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia. 2002;43(6):603-608.
11. Samadani U, Baltuch GH. Anterior thalamic nucleus stimulation for epilepsy. Acta Neurochir Suppl. 2007;97(pt 2):343-346.
12. Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bingaman WE. Longterm results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure. 2006;15(7):491-503.
13. Parrent A, Almeida CS. Deep brain stimulation and cortical stimulation in the treatment of epilepsy. Adv Neurol. 2006;97:563-572.
14. DeGiorgio CM, Shewmon DA, Whitehurst T. Trigeminal nerve stimulation for epilepsy. Neurology. 2003;61(3):421-422.
15. Luders H. Brain stimulation and epilepsy: Novel approaches for seizure control. Suppl Clin Neurophysiol. 2004;57:379-382.
16. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1(8437):1106-1107.
17. Lüders H. Deep Brain Stimulation and Epilepsy. London, United kingdom: Martin Dunitz; 2004.
18. Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science. 2009;324(5925): 354-359.
19. Devinsky O. Electrical and magnetic stimulation of the central nervous system. In: Devinsky O, Beric A, Dogali M, eds. Electrical and Magnetic Stimulation of the Brain and Spinal Cord. New York, NY: Raven Press; 1993:1-16.
20. Gowers WR. Epilepsy and Other Chronic Convulsive Diseases; Their Causes, Symptoms and Treatment. New York, NY: Dover Publications; 1964.
21. Arateus. In: Adams F, trans-ed. The Extant Works of Arateus, the Cappadocian. London, United Kingdom: Sydenham Society; 1856:244.
22. Parent A. Giovanni Aldini: From animal electricity to human brain stimulation. Can J Neurol Sci. 2004;31(4):576-584.
23. Bartholow R. Experimental investigation into the functions of the human brain. Am J Med Sci. 1874;67:305-313.
24. Penfield W. Temporal lobe epilepsy. Br J Surg. 1954;41(168):337-343.
25. Penfield W, Jasper HH. Epilepsy and the Functional Anatomy of the Human Brain. 1st ed. Boston, MA: Little, Brown; 1954.
26. Ramey ER, O'Doherty DS. Electrical Studies on the Unanesthetized Brain. New York, NY: Paul B. Hoeber; 1960.
27. Pool JL. Psychosurgery in older people. J Am Geriatr Soc. 1954;2(7):456-466.
28. Cooke PM, Snider RS. Some cerebellar influences on electrically-induced cerebral seizures. Epilepsia. 1955;4(1):19-28.
29. Velasco F, Velasco M, Ogarrio C, Fanghanel G. Electrical stimulation of the centromedian thalamic nucleus in the treatment of convulsive seizures: A preliminary report. Epilepsia. 1987;28(4):421-430.
30. Velasco M, Velasco F, Velasco AL, Velasco G, Jimenez F. Effect of chronic electrical stimulation of the centromedian thalamic nuclei on various intractable seizure patterns: II. Psychological performance and background EEG activity. Epilepsia. 1993;34(6):1065-1074.
31. Velasco F, Velasco M, Velasco AL, Jimenez F, Marquez I, Rise M. Electrical stimulation of the centromedian thalamic nucleus in control of seizures: Longterm studies. Epilepsia. 1995;36(1):63-71.
32. Velasco F, Velasco M, Velasco AL, Jimenez F. Effect of chronic electrical stimulation of the centromedian thalamic nuclei on various intractable seizure patterns: I. Clinical seizures and paroxysmal EEG activity. Epilepsia. 1993;34(6): 1052-1064.
33. Velasco AL, Velasco F, Jimenez F, et al. Neuromodulation of the centromedian thalamic nuclei in the treatment of generalized seizures and the improvement of the quality of life in patients with Lennox-Gastaut syndrome. Epilepsia. 2006;47(7):1203-1212.
34. Velasco M, Velasco F, Alcala H, Davila G, Diaz-de-Leon AE. Epileptiform EEG activity of the centromedian thalamic nuclei in children with intractable generalized seizures of the Lennox-Gastaut syndrome. Epilepsia. 1991;32(3): 310-321.
35. Velasco F, Velasco AL, Velasco M, Jimenez F, Carrillo-Ruiz JD, Castro G. Deep brain stimulation for treatment of the epilepsies: The centromedian thalamic target. Acta Neurochir Suppl. 2007;97(pt 2):337-342.
36. Velasco M, Velasco F, Velasco AL. Centromedian-thalamic and hippocampal electrical stimulation for the control of intractable epileptic seizures. J Clin Neurophysiol. 2001;18(6):495-513.
37. Velasco M, Velasco F, Velasco AL, Jimenez F, Brito F, Marquez I. Acute and chronic electrical stimulation of the centromedian thalamic nucleus: Modulation of reticulo-cortical systems and predictor factors for generalized seizure control. Arch Med Res. 2000;31(3):304-315.
38. Velasco M, Velasco F, Velasco AL, et al. Electrocortical and behavioral responses produced by acute electrical stimulation of the human centromedian thalamic nucleus. Electroencephalogr Clin Neurophysiol. 1997;102(6):461-471.
39. Velasco F, Velasco M, Jimenez F, et al. Predictors in the treatment of difficult-tocontrol seizures by electrical stimulation of the centromedian thalamic nucleus. Neurosurgery. 2000;47(2):295-304; discussion 295-304.
40. Fisher RS, Uematsu S, Krauss GL, et al. Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures. Epilepsia. 1992;33(5):841-851.
41. Andrade DM, Zumsteg D, Hamani C, et al. Long-term follow-up of patients with thalamic deep brain stimulation for epilepsy. Neurology. 2006;66(10): 1571-1573.
42. Lee KJ, Jang KS, Shon YM. Chronic deep brain stimulation of subthalamic and anterior thalamic nuclei for controlling refractory partial epilepsy. Acta Neurochir Suppl. 2006;99:87-91.
43. Hamani C, Ewerton FI, Bonilha SM, Ballester G, Mello LE, Lozano AM. Bilateral anterior thalamic nucleus lesions and high-frequency stimulation are protective against pilocarpine-induced seizures and status epilepticus. Neurosurgery. 2004;54(1):191-195; discussion 195-197.
44. Kerrigan JF, Litt B, Fisher RS, et al. Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy. Epilepsia. 2004;45(4):346-354.
45. Cooper IS, Upton AR, Amin I, Garnett S, Brown GM, Springman M. Evoked metabolic responses in the limbic-striate system produced by stimulation of anterior thalamic nucleus in man. Int J Neurol. 1984;18:179-187.
46. Lim SN, Lee ST, Tsai YT, et al. Long-term anterior thalamus stimulation for intractable epilepsy. Chang Gung Med J. 2008;31(3):287-296.
47. Upton AR, Amin I, Garnett S, Springman M, Nahmias C, Cooper IS. Evoked metabolic responses in the limbic-striate system produced by stimulation of anterior thalamic nucleus in man. Pacing Clin Electrophysiol. 1987;10(1 pt 2): 217-225.
48. Chkhenkeli SA, Sramka M, Lortkipanidze GS, et al. Electrophysiological effects and clinical results of direct brain stimulation for intractable epilepsy. Clin Neurol Neurosurg. 2004;106(4):318-329.
49. Sramka M, Fritz G, Gajdosova D, Nadvornik P. Central stimulation treatment of epilepsy. Acta Neurochir Suppl (Wien). 1980;30:183-187.
50. Benabid AL, Minotti L, Koudsie A, de Saint Martin A, Hirsch E. Antiepileptic effect of high-frequency stimulation of the subthalamic nucleus (corpus luysi) in a case of medically intractable epilepsy caused by focal dysplasia: A 30-month follow-up: Technical case report. Neurosurgery. 2002;50(6):1385-1391; discussion 1391-1392.
51. Chabardes S, Kahane P, Minotti L, Koudsie A, Hirsch E, Benabid AL. Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus. Epileptic Disord. 2002;4(suppl 3):S83-S93.
52. Loddenkemper T, Pan A, Neme S, et al. Deep brain stimulation in epilepsy. J Clin Neurophysiol. 2001;18(6):514-532.
53. Dinner DS, Neme S, Nair D, et al. EEG and evoked potential recording from the subthalamic nucleus for deep brain stimulation of intractable epilepsy. Clin Neurophysiol. 2002;113(9):1391-1402.
54. Handforth A, DeSalles AA, Krahl SE. Deep brain stimulation of the subthalamic nucleus as adjunct treatment for refractory epilepsy. Epilepsia. 2006;47(7): 1239-1241.
55. Shon YM, Lee KJ, Kim HJ, et al. Effect of chronic deep brain stimulation of the subthalamic nucleus for frontal lobe epilepsy: Subtraction SPECT analysis. Stereotact Funct Neurosurg. 2005;83(2-3):84-90.
56. Vesper J, Steinhoff B, Rona S, et al. Chronic high-frequency deep brain stimulation of the STN/SNr for progressive myoclonic epilepsy. Epilepsia. 2007;48(10): 1984-1989.
57. van Rijckevorsel K, Abu Serieh B, de Tourtchaninoff M, Raftopoulos C. Deep EEG recordings of the mammillary body in epilepsy patients. Epilepsia. 2005;46(5):781-785.
58. Duprez TP, Serieh BA, Raftopoulos C. Absence of memory dysfunction after bilateral mammillary body and mammillothalamic tract electrode implantation: Preliminary experience in three patients. AJNR Am J Neuroradiol. 2005;26(1): 195-197; author reply 197-198.
59. Velasco M, Velasco F, Velasco AL, et al. Subacute electrical stimulation of the hippocampus blocks intractable temporal lobe seizures and paroxysmal EEG activities. Epilepsia. 2000;41(2):158-169.
60. Velasco AL, Velasco M, Velasco F, et al. Subacute and chronic electrical stimulation of the hippocampus on intractable temporal lobe seizures: Preliminary report. Arch Med Res. 2000;31(3):316-328.
61. Boon P, Vonck K, De Herdt V, et al. Deep brain stimulation in patients with refractory temporal lobe epilepsy. Epilepsia. 2007;48(8):1551-1560.
62. Pollo C, Villemure JG. Rationale, mechanisms of efficacy, anatomical targets and future prospects of electrical deep brain stimulation for epilepsy. Acta Neurochir Suppl. 2007;97(pt 2):311-320.
63. Van Roost D, Boon P, Vonck K, Caemaert J. Neurosurgical aspects of temporal deep brain stimulation for epilepsy. Acta Neurochir Suppl. 2007;97(pt 2): 333-336.
64. Velasco AL, Velasco F, Velasco M, Jimenez F, Carrillo-Ruiz JD, Castro G. The role of neuromodulation of the hippocampus in the treatment of intractable complex partial seizures of the temporal lobe. Acta Neurochir Suppl. 2007;97 (pt 2):329-332.
65. Velasco AL, Velasco F, Velasco M, Trejo D, Castro G, Carrillo-Ruiz JD. Electrical stimulation of the hippocampal epileptic foci for seizure control: A double-blind, long-term follow-up study. Epilepsia. 2007;48(10):1895-1903.
66. Vonck K, Boon P, Achten E, De Reuck J, Caemaert J. Long-term amygdalohippocampal stimulation for refractory temporal lobe epilepsy. Ann Neurol. 2002;52(5):556-565.
67. Vonck K, Boon P, Claeys P, Dedeurwaerdere S, Achten R, Van Roost D. Longterm deep brain stimulation for refractory temporal lobe epilepsy. Epilepsia. 2005;46(suppl 5):98-99.
68. Vonck K, Boon P, Van Roost D. Anatomical and physiological basis and mechanism of action of neurostimulation for epilepsy. Acta Neurochir Suppl. 2007;97(pt 2):321-328.
69. Vonck K, Boon P, Goossens L, et al. Neurostimulation for refractory epilepsy. Acta Neurol Belg. 2003;103(4):213-217.
70. Feinstein B, Gleason CA, Libet B. Stimulation of locus coeruleus in man. Preliminary trials for spasticity and epilepsy. Stereotact Funct Neurosurg. 1989;52(1):26-41.
71. Khan S, Wright I, Javed S, et al. High frequency stimulation of the mamillothalamic tract for the treatment of resistant seizures associated with hypothalamic hamartoma. Epilepsia. 2009;50(6):1608-1611.
72. Engel J, Pedley TA. Epilepsy: A Comprehensive Textbook. 2nd ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
73. Zabara J. Time course of seizure control to brief repetitive stimuli. Epilepsia. 1985;26(5):518.
74. Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: Preliminary results. Epilepsia. 1990;31(suppl 2): S40-S43.
75. Vagal nerve stimulation for epilepsy. Arch Dis Child. 1999;81(4):342.
76. Biraben A, Stefani C. [Vagal nerve stimulation as a treatment of epilepsy]. Rev Neurol (Paris). 2005;161(1):128-132.
77. Camfield PR, Camfield CS. Vagal nerve stimulation for treatment of children with epilepsy. J Pediatr. 1999;134(5):532-533.
78. Robinson RO. Vagal nerve stimulation for epilepsy. Arch Dis Child. 2000;82 (4):336.
79. Benifla M, Rutka JT, Logan W, Donner EJ. Vagal nerve stimulation for refractory epilepsy in children: Indications and experience at The Hospital for Sick Children. Childs Nerv Syst. 2006;22(8):1018-1026.
80. Heyman E, Lahat E, Lotan G. [Vagal nerve stimulation for refractory epilepsy in children]. Harefuah. 2008;147(2):136-138, 182.
81. Bremer A, Eriksson AS, Roste GK, Knudtzen B, Nakken KO. [Vagal nerve stimulation in children with drug-resistant epilepsy]. Tidsskr Nor Laegeforen. 2006;126(7):896-898.
82. Morrow JI, Bingham E, Craig JJ, Gray WJ. Vagal nerve stimulation in patients with refractory epilepsy. Effect on seizure frequency, severity and quality of life. Seizure. 2000;9(6):442-445.
83. Murphy JV, Torkelson R, Dowler I, Simon S, Hudson S. Vagal nerve stimulation in refractory epilepsy: The first 100 patients receiving vagal nerve stimulation at a pediatric epilepsy center. Arch Pediatr Adolesc Med. 2003;157(6): 560-564.
84. Vonck K, De Herdt V, Boon P. Vagal nerve stimulation-a 15-year survey of an established treatment modality in epilepsy surgery. Adv Tech Stand Neurosurg. 2009;34:111-146.
85. Iriarte J, Urrestarazu E, Lzaro D, Schlumberger E. [Vagal stimulation in the treatment of epilepsy]. Rev Neurol. 2002;34(6):511-518.
86. Chadwick D. Vagal-nerve stimulation for epilepsy. Lancet. 2001;357(9270): 1726-1727.
87. Koszewski W, Bacia T, Rysz A. [Vagus nerve stimulation (VNS) in the treatment of drug-resistant epilepsy. A 4-year follow-up evaluation of VNS treatment efficacy]. Neurol Neurochir Pol. 2003;37(3):573-586.
88. Zamponi N, Rychlicki F, Corpaci L, Cesaroni E, Trignani R. Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children. Neurosurg Rev. 2008;31(3):291-297.
89. Rafael H, Moromizato P. Vagus nerve stimulation (VNS) may be useful in treating patients with symptomatic generalized epilepsy. Epilepsia. 1998;39 (9):1018.
90. Koren MS, Holmes MD. Vagus nerve stimulation does not lead to significant changes in body weight in patients with epilepsy. Epilepsy Behav. 2006;8(1): 246-249.
91. Buoni S, Mariottini A, Pieri S, et al. Vagus nerve stimulation for drug-resistant epilepsy in children and young adults. Brain Dev. 2004;26(3):158-163.
92. Vagus nerve stimulation for epilepsy. Clin Privil White Pap. 2000;(31):1-8.
93. Milby AH, Halpern CH, Baltuch GH. Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics. 2008;5(1):75-85.
94. Boon P, Vonck K, Van Walleghem P, D'Have M, Caemaert J, De Reuck J. Vagus nerve stimulation for epilepsy, clinical efficacy of programmed and magnet stimulation. Acta Neurochir Suppl. 2002;79:93-98.
95. Binnie CD. Vagus nerve stimulation for epilepsy: A review. Seizure. 2000;9(3): 161-169.
96. Bunch S, DeGiorgio CM, Krahl S, et al. Vagus nerve stimulation for epilepsy: Is output current correlated with acute response? Acta Neurol Scand. 2007;116(4): 217-220.
97. DeGiorgio C, Heck C, Bunch S, et al. Vagus nerve stimulation for epilepsy: Randomized comparison of three stimulation paradigms. Neurology. 2005;65(2): 317-319.
98. Kanner AM. Vagus nerve stimulation for generalized epilepsy?⋯ Show me the evidence! Epilepsy Curr. 2008;8(2):35-36.
99. Labar D. Vagus nerve stimulation for intractable epilepsy in children. Dev Med Child Neurol. 2000;42(7):496-499.
100. Major P, Thiele EA. Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex. Epilepsy Behav. 2008;13(2):357-360.
101. McLachlan RS. Vagus nerve stimulation for intractable epilepsy: A review. J Clin Neurophysiol. 1997;14(5):358-368.
102. Kawai K. [Vagus nerve stimulation for intractable epilepsy: Implantation of vagus nerve stimulator]. No Shinkei Geka. 2008;36(11):979-989.
103. Sakas DE, Korfias S, Nicholson CL, et al. Vagus nerve stimulation for intractable epilepsy: Outcome in two series combining 90 patients. Acta Neurochir Suppl. 2007;97(pt 2):287-291.
104. Ardesch JJ, Buschman HP, Wagener-Schimmel LJ, van der Aa HE, Hageman G. Vagus nerve stimulation for medically refractory epilepsy: A long-term follow-up study. Seizure. 2007;16(7):579-585.
105. Boon P, Vonck K, Vandekerckhove T, et al. Vagus nerve stimulation for medically refractory epilepsy; efficacy and cost-benefit analysis. Acta Neurochir (Wien). 1999;141(5):447-452; discussion 453.
106. Labar D, Murphy J, Tecoma E. Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group. Neurology. 1999;52(7):1510-1512.
107. Tatum WO IV, Ferreira JA, Benbadis SR, et al. Vagus nerve stimulation for pharmacoresistant epilepsy: Clinical symptoms with end of service. Epilepsy Behav. 2004;5(1):128-132.
108. Boon P, Vonck K, De Reuck J, Caemaert J. Vagus nerve stimulation for refractory epilepsy. Seizure. 2001;10(6):456-458; quiz 458-460.
109. Boon P, Vonck K, De Reuck J, Caemaert J. Vagus nerve stimulation for refractory epilepsy. Seizure. 2001;10(6):448-455.
110. Shahwan A, Bailey C, Maxiner W, Harvey AS. Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction. Epilepsia. 2009;50(5):1220-1228.
111. De Herdt V, Boon P, Ceulemans B, et al. Vagus nerve stimulation for refractory epilepsy: A Belgian multicenter study. Eur J Paediatr Neurol. 2007;11(5): 261-269.
112. Vonck K, Thadani V, Gilbert K, et al. Vagus nerve stimulation for refractory epilepsy: A transatlantic experience. J Clin Neurophysiol. 2004;21(4):283-289.
113. Hui AC, Lam JM, Wong KS, Kay R, Poon WS. Vagus nerve stimulation for refractory epilepsy: Long term efficacy and side-effects. Chin Med J (Engl). 2004;117(1):58-61.
114. Ng M, Devinsky O. Vagus nerve stimulation for refractory idiopathic generalised epilepsy. Seizure. 2004;13(3):176-178.
115. Labar D, Nikolov B, Tarver B, Fraser R. Vagus nerve stimulation for symptomatic generalized epilepsy: A pilot study. Epilepsia. 1998;39(2):201-205.
116. Alsaadi TM, Laxer KD, Barbaro NM, Marks WJ Jr, Garcia PA. Vagus nerve stimulation for the treatment of bilateral independent temporal lobe epilepsy. Epilepsia. 2001;42(7):954-956.
117. Amar AP. Vagus nerve stimulation for the treatment of intractable epilepsy. Expert Rev Neurother. 2007;7(12):1763-1773.
118. Garcia-March G, Sanchez-Ledesma MJ, Broseta J. [Vagus nerve stimulation for the treatment of refractory epilepsy. State of the art]. Neurocirugia (Astur). 2008;19(5):416-426.
119. Hallbook T, Lundgren J, Stjernqvist K, Blennow G, Stromblad LG, Rosen I. Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood. Seizure. 2005;14(7):504-513.
120. Lundgren J, Amark P, Blennow G, Stromblad LG, Wallstedt L. Vagus nerve stimulation in 16 children with refractory epilepsy. Epilepsia. 1998;39(8):809-813.
121. Heberle C, Berquin P, Larnicol N,Wallois F. Vagus nerve stimulation in a case of epilepsy with CSWSS: Respiratory side effects during sleep. Epilepsia. 2002;43(10): 1268-1270.
122. Kabir SM, Rajaraman C, Rittey C, Zaki HS, Kemeny AA, McMullan J. Vagus nerve stimulation in children with intractable epilepsy: Indications, complications and outcome. Childs Nerv Syst. 2009;25(9):1097-1100.
123. You SJ, Kang HC, Kim HD, et al. Vagus nerve stimulation in intractable childhood epilepsy: A Korean multicenter experience. J Korean Med Sci. 2007;22 (3):442-445.
124. Majoie HJ, Berfelo MW, Aldenkamp AP, Renier WO, Kessels AG. Vagus nerve stimulation in patients with catastrophic childhood epilepsy, a 2-year follow-up study. Seizure. 2005;14(1):10-18.
125. Kang HC, Hwang YS, Kim DS, Kim HD. Vagus nerve stimulation in pediatric intractable epilepsy: A Korean bicentric study. Acta Neurochir Suppl. 2006;99:93-96.
126. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res. 2000;42(2-3):203-210.
127. Malow BA, Edwards J, Marzec M, Sagher O, Ross D, Fromes G. Vagus nerve stimulation reduces daytime sleepiness in epilepsy patients. Neurology. 2001;57(5): 879-884.
128. Amar AP, Apuzzo ML, Liu CY. Vagus nerve stimulation therapy after failed cranial surgery for intractable epilepsy: Results from the vagus nerve stimulation therapy patient outcome registry. Neurosurgery. 2004;55(5):1086- 1093.
129. Sirven JI, Sperling M, Naritoku D, et al. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology. 2000;54(5):1179-1182.
130. Bernstein AL, Barkan H, Hess T. Vagus nerve stimulation therapy for pharmacoresistant epilepsy: Effect on health care utilization. Epilepsy Behav. 2007;10(1):134-137.
131. Labiner DM, Ahern GL. Vagus nerve stimulation therapy in depression and epilepsy: Therapeutic parameter settings. Acta Neurol Scand. 2007;115(1):23-33.
132. Helmers SL, Wheless JW, Frost M, et al. Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: Retrospective study. J Child Neurol. 2001;16(11):843-848.
133. Heck C, Helmers SL, DeGiorgio CM. Vagus nerve stimulation therapy, epilepsy, and device parameters: Scientific basis and recommendations for use. Neurology. 2002;59(6 suppl 4):S31-S37.
134. Spanaki MV, Allen LS, Mueller WM, Morris GL III. Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center. Seizure. 2004;13(8):587-590.
135. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2002;1(8):477-482.
136. Lesser RP, Kim SH, Beyderman L, et al. Brief bursts of pulse stimulation terminate afterdischarges caused by cortical stimulation. Neurology. 1999;53(9): 2073-2081.
137. Kinoshita M, Ikeda A, Matsuhashi M, et al. Electric cortical stimulation suppresses epileptic and background activities in neocortical epilepsy and mesial temporal lobe epilepsy. Clin Neurophysiol. 2005;116(6):1291-1299.
138. Yamamoto J, Ikeda A, Satow T, et al. Low-frequency electric cortical stimulation has an inhibitory effect on epileptic focus in mesial temporal lobe epilepsy. Epilepsia. 2002;43(5):491-495.
139. Osorio I, Frei MG, Manly BF, Sunderam S, Bhavaraju NC, Wilkinson SB. An introduction to contingent (closed-loop) brain electrical stimulation for seizure blockage, to ultra-short-term clinical trials, and to multidimensional statistical analysis of therapeutic efficacy. J Clin Neurophysiol. 2001;18(6):533-544.
140. Reimer GR, Grimm RJ, Dow RS. Effects of cerebellar stimulation on cobaltinduced epilepsy in the cat. Electroencephalogr Clin Neurophysiol. 1967;23(5): 456-462.
141. Grimm RJ, Frazee JG, Bell CC, Kawasaki T, Dow RS. Quantitative studies in cobalt model epilepsy: The effect of cerebellar stimulation. Int J Neurol. 1970;7(2): 126-140.
142. Krauss GL, Fisher RS. Cerebellar and thalamic stimulation for epilepsy. Adv Neurol. 1993;63:231-245.
143. Testa G, Pellegrini A, Giaretta D. Effects of electrical stimulation and removal of cerebellar structures in an experimental model of generalized epilepsy. Epilepsia. 1979;20(4):447-454.
144. Dow RS, Fernandez-Guardiola A, Manni E. The influence of the cerebellum on experimental epilepsy. Electroencephalogr Clin Neurophysiol. 1962;14(3):383-398.
145. Laxer KD, Robertson LT, Julien RM, Dow RS. Phenytoin: Relationship between cerebellar function and epileptic discharges. Adv Neurol. 1980;27:415-427.
146. Cooper IS, Amin I, Riklan M, Waltz JM, Poon TP. Chronic cerebellar stimulation in epilepsy. Clinical and anatomical studies. Arch Neurol. 1976;33(8): 559-570.
147. Cooper IS, Upton AR. Effects of cerebellar stimulation on epilepsy, the EEG and cerebral palsy in man. Electroencephalogr Clin Neurophysiol Suppl. 1978;(34): 349-354.
148. Davis R, Emmonds SE. Cerebellar stimulation for seizure control: 17-year study. Stereotact Funct Neurosurg. 1992;58(1-4):200-208.
149. Davis R. Cerebellar stimulation for seizure control. In: Lozano AM, Philip LG, Ronald RT, eds. Textbook of Stereotactic and Functional Neurosurgery. Berlin, Germany: Springer; 2009:2823.
150. Davis R. Cerebellar stimulation for cerebral palsy spasticity, function, and seizures. Arch Med Res. 2000;31(3):290-299.
151. Van Buren JM, Wood JH, Oakley J, Hambrecht F. Preliminary evaluation of cerebellar stimulation by double-blind stimulation and biological criteria in the treatment of epilepsy. J Neurosurg. 1978;48(3):407-416.
152. Velasco F, Carrillo-Ruiz JD, Brito F, et al. Double-blind, randomized controlled pilot study of bilateral cerebellar stimulation for treatment of intractable motor seizures. Epilepsia. 2005;46(7):1071-1081.
153. Miller JW, Hall CM, Holland KD, Ferrendelli JA. Identification of a median thalamic system regulating seizures and arousal. Epilepsia. 1989;30(4):493-500.
154. Avoli M, Gloor P, Kostopoulos G, Gotman J. An analysis of penicillin-induced generalized spike and wave discharges using simultaneous recordings of cortical and thalamic single neurons. J Neurophysiol. 1983;50(4):819-837.
155. Gloor P. Generalized epilepsy with spike-and-wave discharge: A reinterpretation of its electrographic and clinical manifestations. The 1977 William G. Lennox Lecture, American Epilepsy Society. Epilepsia. 1979;20(5):571-588.
156. Pollen DA, Perot P, Reid KH. Experimental bilateral wave and spike from thalamic stimulation in relation to level of arousal. Electroencephalogr Clin Neurophysiol. 1963;15(6):1017-1028.
157. Velasco M, Velasco F, Velasco AL, Lujan M, Vazquez del Mercado J. Epileptiform EEG activities of the centromedian thalamic nuclei in patients with intractable partial motor, complex partial, and generalized seizures. Epilepsia. 1989;30(3):295-306.
158. Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. Electroencephalogr Clin Neurophysiol. 1949;1(4):455-473.
159. Mirski MA, Ferrendelli JA. Interruption of the mammillothalamic tract prevents seizures in guinea pigs. Science. 1984;226(4670):72-74.
160. Mirski MA, Ferrendelli JA. Anterior thalamic mediation of generalized pentylenetetrazol seizures. Brain Res. 1986;399(2):212-223.
161. Mirski MA, Ferrendelli JA. Selective metabolic activation of the mammillary bodies and their connections during ethosuximide-induced suppression of pentylenetetrazol seizures. Epilepsia. 1986;27(3):194-203.
162. Mirski MA, Ferrendelli JA. Interruption of the connections of the mammillary bodies protects against generalized pentylenetetrazol seizures in guinea pigs. J Neurosci. 1987;7(3):662-670.
163. Mirski MA, McKeon AC, Ferrendelli JA. Anterior thalamus and substantia nigra: Two distinct structures mediating experimental generalized seizures. Brain Res. 1986;397(2):377-380.
164. Mirski MA, Rossell LA, Terry JB, Fisher RS. Anticonvulsant effect of anterior thalamic high frequency electrical stimulation in the rat. Epilepsy Res. 1997;28(2): 89-100.
165. Hamani C, Hodaie M, Chiang J, et al. Deep brain stimulation of the anterior nucleus of the thalamus: Effects of electrical stimulation on pilocarpine-induced seizures and status epilepticus. Epilepsy Res. 2008;78(2-3):117-123.
166. Lado FA. Chronic bilateral stimulation of the anterior thalamus of kainate-treated rats increases seizure frequency. Epilepsia. 2006;47(1):27-32.
167. Cooper IS, Upton AR. Therapeutic implications of modulation of metabolism and functional activity of cerebral cortex by chronic stimulation of cerebellum and thalamus. Biol Psychiatry. 1985;20(7):811-813.
168. Rosenow J, Das K, Rovit RL, Couldwell WT, Irving S. Cooper and his role in intracranial stimulation for movement disorders and epilepsy. Stereotact Funct Neurosurg. 2002;78(2):95-112.
169. Upton AR, Cooper IS, Springman M, Amin I. Suppression of seizures and psychosis of limbic system origin by chronic stimulation of anterior nucleus of the thalamus. Int J Neurol. 1985;19-20:223-230.
170. Sussman NM GH, Jackel RA. Stimulation of thalamic anterior nucleus in medically intractable epilepsy: II Preliminary clinical results [Abstract]. Epilepsia. 1988;29(5):677.
171. Lim SN, Lee ST, Tsai YT, et al. Electrical stimulation of the anterior nucleus of the thalamus for intractable epilepsy: A long-term follow-up study. Epilepsia. 2007;48(2):342-347.
172. Osorio I, Overman J, Giftakis J, Wilkinson SB. High frequency thalamic stimulation for inoperable mesial temporal epilepsy. Epilepsia. 2007;48(8):1561-1571.
173. Andrade DM, Hamani C, Lozano AM, Wennberg RA. Dravet syndrome and deep brain stimulation: Seizure control after 10 years of treatment. Epilepsia. 2010;51(7):1314-1316.
174. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5): 899-908.
175. Benabid AL, Koudsie A, Benazzouz A, et al. Deep brain stimulation for Parkinson's disease. Adv Neurol. 2001;86:405-412.
176. Deransart C, Le BT, Marescaux C, Depaulis A. Role of the subthalamo-nigral input in the control of amygdala-kindled seizures in the rat. Brain Res. 1998;807(1-2):78-83.
177. Lado FA, Velisek L,Moshe SL. The effect of electrical stimulation of the subthalamic nucleus on seizures is frequency dependent. Epilepsia. 2003;44(2):157-164.
178. Velisek L, Veliskova J, Moshe SL. Electrical stimulation of substantia nigra pars reticulata is anticonvulsant in adult and young male rats. Exp Neurol. 2002;173(1): 145-152.
179. Veliskova J, Velsek L, Moshe SL. Subthalamic nucleus: A new anticonvulsant site in the brain. Neuroreport. 1996;7(11):1786-1788.
180. Vercueil L, Benazzouz A, Deransart C, et al. High-frequency stimulation of the subthalamic nucleus suppresses absence seizures in the rat: Comparison with neurotoxic lesions. Epilepsy Res. 1998;31(1):39-46.
181. Gale K. Role of the substantia nigra in GABA-mediated anticonvulsant actions. Adv Neurol. 1986;44:343-364.
182. Iadarola MJ, Gale K. Substantia nigra: Site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science. 1982;218(4578):1237-1240.
183. Usui N, Maesawa S, Kajita Y, Endo O, Takebayashi S, Yoshida J. Suppression of secondary generalization of limbic seizures by stimulation of subthalamic nucleus in rats. J Neurosurg. 2005;102(6):1122-1129.
184. La Grutta V, Sabatino M, Gravante G, Morici G, Ferraro G, La Grutta G. A study of caudate inhibition on an epileptic focus in the cat hippocampus. Arch Int Physiol Biochim. 1988;96(2):113-120.
185. La Grutta V, Sabatino M. Focal hippocampal epilepsy: Effect of caudate stimulation. Exp Neurol. 1988;99(1):38-49.
186. Oakley JC, Ojemann GA. Effects of chronic stimulation of the caudate nucleus on a preexisting alumina seizure focus. Exp Neurol. 1982;75(2):360-367.
187. Sramka M, Chkhenkeli SA. Clinical experience in intraoperational determination of brain inhibitory structures and application of implanted neurostimulators in epilepsy. Stereotact Funct Neurosurg. 1990;54-55(1-8):56-59.
188. Kellinghaus C, Loddenkemper T, Moddel G, et al. [Electric brain stimulation for epilepsy therapy]. Nervenarzt. 2003;74(8):664-676.
189. Weiss SR, Eidsath A, Li XL, Heynen T, Post RM. Quenching revisited: Low level direct current inhibits amygdala-kindled seizures. Exp Neurol. 1998;154(1):185-192.
190. Weiss SR, Li XL, Rosen JB, Li H, Heynen T, Post RM. Quenching: Inhibition of development and expression of amygdala kindled seizures with low frequency stimulation. Neuroreport. 1995;6(16):2171-2176.
191. Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol. 1969;25(3):295-330.
192. Uthman BM, Wilder BJ, Hammond EJ, Reid SA. Efficacy and safety of vagus nerve stimulation in patients with complex partial seizures. Epilepsia. 1990;31(suppl 2):S44-S50.
193. Wyckhuys T, De Smedt T, Claeys P, et al. High frequency deep brain stimulation in the hippocampus modifies seizure characteristics in kindled rats. Epilepsia. 2007;48(8):1543-1550.
194. McLachlan RS, Pigott S, Tellez-Zenteno JF, Wiebe S, Parrent A. Bilateral hippocampal stimulation for intractable temporal lobe epilepsy: Impact on seizures and memory. Epilepsia. 2010;51(2):304-307.
195. Lesser RP, Luders H, Klem G, Dinner DS, Morris HH, Hahn J. Cortical afterdischarge and functional response thresholds: Results of extraoperative testing. Epilepsia. 1984;25(5):615-621.
196. Motamedi GK, Lesser RP, Miglioretti DL, et al. Optimizing parameters for terminating cortical afterdischarges with pulse stimulation. Epilepsia. 2002;43(8): 836-846.
197. Franaszczuk PJ, Kudela P, Bergey GK. External excitatory stimuli can terminate bursting in neural network models. Epilepsy Res. 2003;53(1-2):65-80.
198. Montgomery EB Jr, Baker KB. Mechanisms of deep brain stimulation and future technical developments. Neurol Res. 2000;22(3):259-266.
199. Kinoshita M, Ikeda A, Matsumoto R, et al. Electric stimulation on human cortex suppresses fast cortical activity and epileptic spikes. Epilepsia. 2004;45(7): 787-791.
200. Yamamoto J, Ikeda A, Kinoshita M, et al. Low-frequency electric cortical stimulation decreases interictal and ictal activity in human epilepsy. Seizure. 2006;15(7):520-527.
201. Fountas KN, Smith JR. A novel closed-loop stimulation system in the control of focal, medically refractory epilepsy. Acta Neurochir Suppl. 2007;97(pt 2): 357-362.
202. Sun C, Mtchedlishvili Z, Bertram EH, Erisir A, Kapur J. Selective loss of dentate hilar interneurons contributes to reduced synaptic inhibition of granule cells in an electrical stimulation-based animal model of temporal lobe epilepsy. J Comp Neurol. 2007;500(5):876-893.
203. Sun FT, Morrell MJ, Wharen RE Jr. Responsive cortical stimulation for the treatment of epilepsy. Neurotherapeutics. 2008;5(1):68-74.
204. Mirski MA, Fisher RS. Electrical stimulation of the mammillary nuclei increases seizure threshold to pentylenetetrazol in rats. Epilepsia. 1994;35(6):1309-1316.
205. Osorio I, Frei MG, Sunderam S, et al. Automated seizure abatement in humans using electrical stimulation. Ann Neurol. 2005;57(2):258-268.
206. Osorio I, Frei MG. Comments on requirements for valid and meaningful assessment of therapies for epilepsy and a note of clarification about "open-" vs. "closed-loop" modalities. Epilepsia. 2007;48(2):406.
207. Osorio I, Frei MG, Wilkinson SB. Real-time automated detection and quantitative analysis of seizures and short-term prediction of clinical onset. Epilepsia. 1998;39(6):615-627.
208. Peters TE, Bhavaraju NC, Frei MG, Osorio I. Network system for automated seizure detection and contingent delivery of therapy. J Clin Neurophysiol. 2001;18(6):545-549.
209. Adeli H, Ghosh-Dastidar S, Dadmehr N. A wavelet-chaos methodology for analysis of EEGs and EEG subbands to detect seizure and epilepsy. IEEE Trans Biomed Eng. 2007;54(2):205-211.
210. Adeli H, Zhou Z, Dadmehr N. Analysis of EEG records in an epileptic patient using wavelet transform. J Neurosci Methods. 2003;123(1):69-87.
211. Ghosh-Dastidar S, Adeli H, Dadmehr N. Mixed-band wavelet-chaos-neural network methodology for epilepsy and epileptic seizure detection. IEEE Trans Biomed Eng. 2007;54(9):1545-1551.
212. Ghosh-Dastidar S, Adeli H, Dadmehr N. Principal component analysis-enhanced cosine radial basis function neural network for robust epilepsy and seizure detection. IEEE Trans Biomed Eng. 2008;55(2 pt 1):512-518.
213. Fountas KN, Smith JR, Murro AM, Politsky J, Park YD, Jenkins PD. Implantation of a closed-loop stimulation in the management of medically refractory focal epilepsy: A technical note. Stereotact Funct Neurosurg. 2005;83(4):153-158.
214. Morrell M, RNS System Investigators (2009). Results of a multicenter double blinded randomized controlled pivotal investigation of the RNS system for treatment of intractable partial epilepsy in adults. Epilepsia. 2009;50(suppl 11):1-502.
215. Kossoff EH, Ritzl EK, Politsky JM, et al. Effect of an external responsive neurostimulator on seizures and electrographic discharges during subdural electrode monitoring. Epilepsia. 2004;45(12):1560-1567.
216. Barker AT, Freeston IL, Jalinous R, Jarratt JA. Magnetic stimulation of the human brain and peripheral nervous system: An introduction and the results of an initial clinical evaluation. Neurosurgery. 1987;20(1):100-109.
217. Rossini PM, Barker AT, Berardelli A, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: Basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. 1994;91(2):79-92.
218. Pascual-Leone A, Bartres-Faz D, Keenan JP. Transcranial magnetic stimulation: Studying the brain-behaviour relationship by induction of 'virtual lesions'. Philos Trans R Soc Lond B Biol Sci. 1999;354(1387):1229-1238.
219. Pascual-Leone A, Tarazona F, Keenan J, Tormos JM, Hamilton R, Catala MD. Transcranial magnetic stimulation and neuroplasticity. Neuropsychologia. 1999;37(2): 207-217.
220. Theodore WH, Hunter K, Chen R, et al. Transcranial magnetic stimulation for the treatment of seizures: A controlled study. Neurology. 2002;59(4):560-562.
221. Akamatsu N, Fueta Y, Endo Y, Matsunaga K, Uozumi T, Tsuji S. Decreased susceptibility to pentylenetetrazol-induced seizures after low-frequency transcranial magnetic stimulation in rats. Neurosci Lett. 2001;310(2-3):153-156.
222. Tergau F, Naumann U, Paulus W, Steinhoff BJ. Low-frequency repetitive transcranial magnetic stimulation improves intractable epilepsy. Lancet. 1999;353 (9171):2209.
223. Tergau FND, Rosenow F. Frequency repetitive transcranial magnetic stimulation for treatment of drug-resistant epilepsy. Epilepsia. 2002;43(suppl 7):S53.
224. Menkes DL, Gruenthal M. Slow-frequency repetitive transcranial magnetic stimulation in a patient with focal cortical dysplasia. Epilepsia. 2000;41(2): 240-242.
225. Cantello R, Rossi S, Varrasi C, et al. Slow repetitive TMS for drug-resistant epilepsy: Clinical and EEG findings of a placebo-controlled trial. Epilepsia. 2007;48(2):366-374.
226. Fregni F, Otachi PT, Do Valle A, et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in patients with refractory epilepsy. Ann Neurol. 2006;60(4):447-455.
227. Ricardo JA, Koh ET. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res. 1978;153(1):1-26.
228. Krahl SE, Clark KB, Smith DC, Browning RA. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia. 1998;39(7): 709-714.
229. Hammond EJ, Uthman BM, Reid SA, Wilder BJ. Electrophysiologic studies of cervical vagus nerve stimulation in humans: II. Evoked potentials. Epilepsia. 1992;33(6):1021-1028.
230. Hammond EJ, Uthman BM, Reid SA,Wilder BJ. Electrophysiological studies of cervical vagus nerve stimulation in humans: I. EEG effects. Epilepsia. 1992;33(6): 1013-1020.
231. Bailey P, Bermer F. A sensory cortical representation of the vagus nerve. J Neurophysiol. 1938;1:405-412.
232. Zanchetti A, Wang SC, Moruzzi G. The effect of vagal afferent stimulation on the EEG pattern of the cat. Electroencephalogr Clin Neurophysiol. 1952;4(3): 357-361.
233. Radna RJ, MacLean PD. Vagal elicitation of respiratory-type and other unit responses in basal limbic structures of squirrel monkeys. Brain Res. 1981;213(1): 45-61.
234. McLachlan RS. Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia. 1993;34(5):918-923.
235. Woodbury JW, Woodbury DM. Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: Use of a cuff electrode for stimulating and recording. Pacing Clin Electrophysiol. 1991;14(1):94-107.
236. Woodbury DM, Woodbury JM. Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia. 1990;31(suppl 2):S7-S19.
237. Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia. 1992;33(6):1005-1012.
238. Takaya M, Terry WJ, Naritoku DK. Vagus nerve stimulation induces a sustained anticonvulsant effect. Epilepsia. 1996;37(11):1111-1116.
239. Lockard JS, Congdon WC, DuCharme LL. Feasibility and safety of vagal stimulation in monkey model. Epilepsia. 1990;31(suppl 2):S20-S26.
240. DeGiorgio CM, Apuzzo ML. Surgical anatomy, implantaion technique, and operative complications. In: Schachter SC, Schmidt D, eds. Vagus Nerve Stimulation. London, United Kingdom: Martin Dunitz; 2001:31-50.
241. Amar AP, Heck CN, Levy ML, et al. An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: Rationale, technique, and outcome. Neurosurgery. 1998;43(6):1265-1276; discussion 1276-1280.
242. Ring HA, White S, Costa DC, et al. A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy. Seizure. 2000;9(6): 380-384.
243. Garnett ES, Nahmias C, Scheffel A, Firnau G, Upton AR. Regional cerebral blood flow in man manipulated by direct vagal stimulation. Pacing Clin Electrophysiol. 1992;15(10 pt 2):1579-1580.
244. Ko D HC, Grafton S. vagus nerve stimulation activates central nervous system structures in epileptic patients during PET blood flow imaging. Neurosurgery. 1996;39(2):426-431.
245. Bohning DE, Lomarev MP, Denslow S, Nahas Z, Shastri A, George MS. Feasibility of vagus nerve stimulation-synchronized blood oxygenation leveldependent functional MRI. Invest Radiol. 2001;36(8):470-479.
246. Vonck K, Boon P, Van Laere K, et al. Acute single photon emission computed tomographic study of vagus nerve stimulation in refractory epilepsy. Epilepsia. 2000;41(5):601-609.
247. Henry TR, Votaw JR, Pennell PB, et al. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology. 1999;52(6):1166-1173.
248. Lulic D, Ahmadian A, Baaj AA, Benbadis SR, Vale FL. Vagus nerve stimulation. Neurosurg Focus. 2009;27(3):E5.
249. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, et al. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia. 1994;35(3): 616-626.
250. Ramsay RE, Uthman BM, Augustinsson LE, et al. Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group. Epilepsia. 1994;35(3): 627-636.
251. George R, Salinsky M, Kuzniecky R, et al. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia. 1994;35(3):637-643.
252. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group. Neurology. 1995;45(2):224-230.
253. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial. Neurology. 1998;51(1):48-55.
254. DeGiorgio CM, Schachter SC, Handforth A, et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia. 2000;41(9):1195-1200.
255. Morris GL III, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology. 1999;53(8):1731-1735.
256. Hosain S, Nikalov B, Harden C, Li M, Fraser R, Labar D. Vagus nerve stimulation treatment for Lennox-Gastaut syndrome. J Child Neurol. 2000;15(8): 509-512.
257. Murphy JV. Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group. J Pediatr. 1999;134(5):563-566.
258. Patwardhan RV, Stong B, Bebin EM, Mathisen J, Grabb PA. Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurgery. 2000;47(6):1353-1357; discussion 1357-1358.
259. Dodrill CB, Morris GL. Effects of vagal nerve stimulation on cognition and quality of life in epilepsy. Epilepsy Behav. 2001;2(1):46-53.
260. McGlone J, Valdivia I, Penner M, Williams J, Sadler RM, Clarke DB. Quality of life and memory after vagus nerve stimulator implantation for epilepsy. Can J Neurol Sci. 2008;35(3):287-296.
261. Sanders I, Aviv J, Biller HF. Transcutaneous electrical stimulation of the recurrent laryngeal nerve: A method of controlling vocal cord position. Otolaryngol Head Neck Surg. 1986;95(2):152-157.
262. Ventureyra EC. Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept. Childs Nerv Syst. 2000;16(2):101-102.
263. Fallgatter AJ, Neuhauser B, Herrmann MJ, et al. Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm. 2003;110(12):1437-1443.
264. Kraus T, Hosl K, Kiess O, Schanze A, Kornhuber J, Forster C. BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm. 2007;114(11):1485- 1493.
265. Maksimow K. Interruption of grand mal epileptic seizures by the trigeminal nerve stimulation. Neurol Neurochir Pol. 1976;10(2)205-208.
266. Fanselow EE, Reid AP, Nicolelis MA. Reduction of pentylenetetrazole- induced seizure activity in awake rats by seizure-triggered trigeminal nerve stimulation. J Neurosci. 2000;20(21):8160-8168.
267. DeGiorgio CM, Shewmon A,Murray D, Whitehurst T. Pilot study of trigeminal nerve stimulation (TNS) for epilepsy: A proof-of-concept trial. Epilepsia. 2006;47(7):1213-1215.
268. DeGiorgio CM, Murray D, Markovic D, Whitehurst T. Trigeminal nerve stimulation for epilepsy: Long-term feasibility and efficacy. Neurology. 2009;72(10): 936-938.
269. Schwartz SI, Griffith LS, Neistadt A, Hagfors N. Chronic carotid sinus nerve stimulation in the treatment of essential hypertension. Am J Surg. 1967;114(1): 5-15.
270. Patwardhan RV, Tubbs RS, Killingsworth CR, Rollins DL, SmithWM, Ideker RE. Ninth cranial nerve stimulation for epilepsy control. Part 1: Efficacy in an animal model. Pediatr Neurosurg. 2002;36(5):236-243.
271. Tubbs RS, Patwardhan RV, Oakes WJ. Ninth cranial nerve stimulation for epilepsy control. Part 2: Surgical feasibility in humans. Pediatr Neurosurg. 2002;36(5):244-247.
272. Serralta A, Barcia JA, Ortiz P, Duran C, Hernandez ME, Alos M. Effect of intracerebroventricular continuous infusion of valproic acid versus single i.p. and i.c.v. injections in the amygdala kindling epilepsy model. Epilepsy Res. 2006;70(1):15-26.
273. Oommen J, Kraus AC, Fisher RS. Intraventricular administration of gabapentin in the rat increases flurothyl seizure threshold. Neurosci Lett. 2007;417(3):308-311.
274. Eder HG, Jones DB, Fisher RS. Local perfusion of diazepam attenuates interictal and ictal events in the bicuculline model of epilepsy in rats. Epilepsia. 1997;38(5):516-521.
275. Eder HG, Stein A, Fisher RS. Interictal and ictal activity in the rat cobalt/ pilocarpine model of epilepsy decreased by local perfusion of diazepam. Epilepsy Res. 1997;29(1):17-24.
276. Uemura S, Ienaga K, Higashiura K, Kimura H. Effects of intraamygdaloid injection of taurine and valyltaurine on amygdaloid kindled seizure in rats. Jpn J Psychiatry Neurol. 1991;45(2):383-385.
277. Smith DC, Krahl SE, Browning RA, Barea EJ. Rapid cessation of focally induced generalized seizures in rats through microinfusion of lidocaine hydrochloride into the focus. Epilepsia. 1993;34(1):43-53.
278. Wada Y, NakamuraM, Hasegawa H, Yamaguchi N. Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci Lett. 1993;159(1-2):179-182.
279. Attwell PJ, Koumentaki A, Abdul-Ghani AS, Croucher MJ, Bradford HF. Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats. Brain Res. 1998;787(2):286-291.
280. Croucher MJ, Bradford HF, Sunter DC, Watkins JC. Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. Eur J Pharmacol. 1988;152(1-2):29-38.
281. Kubek MJ, Liang D, Byrd KE, Domb AJ. Prolonged seizure suppression by a single implantable polymeric-TRHmicrodisk preparation. Brain Res. 1998;809(2): 189-197.
282. Boison D, Scheurer L, Tseng JL, Aebischer P, Mohler H. Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer. Exp Neurol. 1999;160(1):164-174.
283. Tamargo RJ, Rossell LA, Kossoff EH, Tyler BM, Ewend MG, Aryanpur JJ. The intracerebral administration of phenytoin using controlled-release polymers reduces experimental seizures in rats. Epilepsy Res. 2002;48(3):145-155.
284. Ludvig N. Localized transmeningeal muscimol prevents neocortical seizures in rats and nonhuman primates: Therapeutic implications. Epilepsia. 2009;50(4): 678-693.
285. Loscher W, Czuczwar SJ, Jackel R, Schwarz M. Effect of microinjections of gamma-vinyl GABA or isoniazid into substantia nigra on the development of amygdala kindling in rats. Exp Neurol. 1987;95(3):622-638.
286. Maggio R, Gale K. Seizures evoked from area tempestas are subject to control by GABA and glutamate receptors in substantia nigra. Exp Neurol. 1989;105(2): 184-188.
287. McNamara JO, Galloway MT, Rigsbee LC, Shin C. Evidence implicating substantia nigra in regulation of kindled seizure threshold. J Neurosci. 1984;4(9): 2410-2417.
288. De Sarro G, Meldrum BS, Reavill C. Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra. Eur J Pharmacol. 1984;106(1): 175-179.
289. Kokaia M, Aebischer P, Elmer E, et al. Seizure suppression in kindling epilepsy by intracerebral implants of GABA-but not by noradrenaline-releasing polymer matrices. Exp Brain Res. 1994;100(3):385-394.
290. Stein AG, Eder HG, Blum DE, Drachev A, Fisher RS. An automated drug delivery system for focal epilepsy. Epilepsy Res. 2000;39(2):103-114.
291. Costantin L, Bozzi Y, Richichi C, et al. Antiepileptic effects of botulinum neurotoxin E. J Neurosci. 2005;25(8):1943-1951.
292. Wang S, Ding M, Wu D, Zhan J, Chen Z. omega-Conotoxin MVIIA inhibits amygdaloid kindled seizures in Sprague-Dawley rats. Neurosci Lett. 2007;413(2): 163-167.
293. Gasior M, White NA, Rogawski MA. Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA. J Pharmacol Exp Ther. 2007;323(2):458-468.
294. Ludvig N, Kuzniecky RI, Baptiste SL, et al. Epidural pentobarbital delivery can prevent locally induced neocortical seizures in rats: The prospect of trans-meningeal pharmacotherapy for intractable focal epilepsy. Epilepsia. 2006;47(11): 1792-1802.
295. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A. 1994;91(6):2076-2080.
296. Haroun RI, Brem H. Local drug delivery. Curr Opin Oncol. 2000;12(3):187-193.
297. Lieberman DM, Laske DW, Morrison PF, Bankiewicz KS, Oldfield EH. Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg. 1995;82(6):1021-1029.
298. Lonser RR, Walbridge S, Garmestani K, et al. Successful and safe perfusion of the primate brainstem: In vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg. 2002;97(4):905-913.
299. Bennewitz MF, Saltzman WM. Nanotechnology for delivery of drugs to the brain for epilepsy. Neurotherapeutics. 2009;6(2):323-336.
300. Linninger AA, Somayaji MR, Mekarski M, Zhang L. Prediction of convectionenhanced drug delivery to the human brain. J Theor Biol. 2008;250(1):125-138.
301. Barry DI, Kikvadze I, Brundin P, Bolwig TG, Bjorklund A, Lindvall O. Grafted noradrenergic neurons suppress seizure development in kindling-induced epilepsy. Proc Natl Acad Sci U S A. 1987;84(23):8712-8715.
302. Bengzon J, Kokaia M, Brundin P, Lindvall O. Seizure suppression in kindling epilepsy by intrahippocampal locus coeruleus grafts: Evidence for an alpha-2-adrenoreceptor mediated mechanism. Exp Brain Res. 1990;81(2):433-437.
303. Clough RW, Browning RA, Maring ML, Statnick MA, Wang C, Jobe PC. Effects of intraventricular locus coeruleus transplants on seizure severity in genetically epilepsy-prone rats following depletion of brain norepinephrine. J Neural Transplant Plast. 1994;5(1):65-79.
304. Kokaia M, Cenci MA, Elmer E, et al. Seizure development and noradrenaline release in kindling epilepsy after noradrenergic reinnervation of the subcortically deafferented hippocampus by superior cervical ganglion or fetal locus coeruleus grafts. Exp Neurol. 1994;130(2):351-361.
305. Cassel JC, Kelche C, Will BE. Susceptibility to pentylenetetrazol-induced and audiogenic seizures in rats with selective fimbria-fornix lesions and intrahippocampal septal grafts. Exp Neurol. 1987;97(3):564-576.
306. Buzsaki G, Ponomareff G, Bayardo F, Shaw T, Gage FH. Suppression and induction of epileptic activity by neuronal grafts. Proc Natl Acad Sci U S A. 1988;85(23):9327-9330.
307. Ferencz I, Kokaia M, Elmer E, Keep M, Kokaia Z, Lindvall O. Suppression of kindling epileptogenesis in rats by intrahippocampal cholinergic grafts. Eur J Neurosci. 1998;10(1):213-220.
308. Camu W, Marlier L, Lerner-Natoli M, Rondouin G, Privat A. Transplantation of serotonergic neurons into the 5,7-DHT-lesioned rat olfactory bulb restores the parameters of kindling. Brain Res. 1990;518(1-2):23-30.
309. Clough R, Statnick M, Maring-Smith M, et al. Fetal raphe transplants reduce seizure severity in serotonin-depleted GEPRs. Neuroreport. 1996;8(1):341-346.
310. Bengzon J, Kokaia Z, Lindvall O. Specific functions of grafted locus coeruleus neurons in the kindling model of epilepsy. Exp Neurol. 1993;122(1):143-154.
311. Clough RW, Browning RA, Maring ML, Jobe PC. Intracerebral grafting of fetal dorsal pons in genetically epilepsy-prone rats: Effects on audiogenic-induced seizures. Exp Neurol. 1991;112(2):195-199.
312. Bortolotto ZA, Calderazzo L, Cavalheiro EA. Some evidence that intrahippocampal grafting of noradrenergic neurons suppresses spontanous seizures in epileptic rats. Braz J Med Biol Res. 1990;23(12):1267-1269.
313. Holmes GL, Thompson JL, Huh K, Holmes C, Carl GF. Effect of neural transplants on seizure frequency and kindling in immature rats following kainic acid. Brain Res Dev Brain Res. 1991;64(1-2):47-56.
314. Fine A, Meldrum BS, Patel S. Modulation of experimentally induced epilepsy by intracerebral grafts of fetal GABAergic neurons. Neuropsychologia. 1990;28(6): 627-634.
315. Loscher W, Ebert U, Lehmann H, Rosenthal C, Nikkhah G. Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra. J Neurosci Res. 1998;51(2):196-209.
316. Thompson K, Anantharam V, Behrstock S, Bongarzone E, Campagnoni A, Tobin AJ. Conditionally immortalized cell lines, engineered to produce and release GABA, modulate the development of behavioral seizures. Exp Neurol. 2000;161(2):481-489.
317. Moshe SL, Brown LL, Kubova H, Veliskova J, Zukin RS, Sperber EF. Maturation and segregation of brain networks that modify seizures. Brain Res. 1994;665(1):141-146.
318. Garant DS, Xu SG, Sperber EF, Moshe SL. Age-related differences in the effects of GABAA agonists microinjected into rat substantia nigra: Pro-and anticonvulsant actions. Epilepsia. 1995;36(10):960-965.
319. Gernert M, Thompson KW, Loscher W, Tobin AJ. Genetically engineered GABA-producing cells demonstrate anticonvulsant effects and long-term transgene expression when transplanted into the central piriform cortex of rats. Exp Neurol. 2002;176(1):183-192.
320. Thompson K. Transplantation of GABA-producing cells for seizure control in models of temporal lobe epilepsy. Neurotherapeutics. 2009;6(2):284-294.
321. Nolte MW, Loscher W, Herden C, Freed WJ, Gernert M. Benefits and risks of intranigral transplantation of GABA-producing cells subsequent to the establishment of kindling-induced seizures. Neurobiol Dis. 2008;31(3):342-354.
322. Thompson KW. Genetically engineered cells with regulatable GABA production can affect afterdischarges and behavioral seizures after transplantation into the dentate gyrus. Neuroscience. 2005;133(4):1029-1037.
323. Castillo CG, Mendoza-Trejo S, Aguilar MB, Freed WJ, Giordano M. Intranigral transplants of a GABAergic cell line produce long-term alleviation of established motor seizures. Behav Brain Res. 2008;193(1):17-27.
324. Castillo CG, Mendoza S, Freed WJ, Giordano M. Intranigral transplants of immortalized GABAergic cells decrease the expression of kainic acid-induced seizures in the rat. Behav Brain Res. 2006;171(1):109-115.
325. Calcagnotto ME, Ruiz LP, Blanco MM, et al. Effect of neuronal precursor cells derived from medial ganglionic eminence in an acute epileptic seizure model. Epilepsia. 2010;51(suppl 3):71-75.
326. Baraban SC, Southwell DG, Estrada RC, et al. Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc Natl Acad Sci U S A. 2009;106(36):15472-15477.
327. Cunningham MG, Connor CM, Carlezon WA Jr, Meloni E. Amygdalar GABAergic-rich neural grafts attenuate anxiety-like behavior in rats. Behav Brain Res. 2009;205(1):146-153.
328. Calcagnotto ME, Zipancic I, Piquer-Gil M, Mello LE, Alvarez-Dolado M. Grafting of GABAergic precursors rescues deficits in hippocampal inhibition. Epilepsia. 2010;51(suppl 3):66-70.
329. Shetty AK, Turner DA. Fetal hippocampal grafts containing CA3 cells restore host hippocampal glutamate decarboxylase-positive interneuron numbers in a rat model of temporal lobe epilepsy. J Neurosci. 2000;20(23):8788-8801.
330. Shetty AK, Zaman V, Turner DA. Pattern of long-distance projections from fetal hippocampal field CA3 and CA1 cell grafts in lesioned CA3 of adult hippocampus follows intrinsic character of respective donor cells. Neuroscience. 2000;99(2):243-255.
331. Shetty AK, Turner DA. Enhanced cell survival in fetal hippocampal suspension transplants grafted to adult rat hippocampus following kainate lesions: A threedimensional graft reconstruction study. Neuroscience. 1995;67(3):561-582.
332. Shetty AK, Turner DA. Development of fetal hippocampal grafts in intact and lesioned hippocampus. Prog Neurobiol. 1996;50(5-6):597-653.
333. Shetty AK, Turner DA. Development of long-distance efferent projections from fetal hippocampal grafts depends upon pathway specificity and graft location in kainate-lesioned adult hippocampus. Neuroscience. 1997;76(4):1205-1219.
334. Shetty AK, Turner DA. Fetal hippocampal cells grafted to kainate-lesioned CA3 region of adult hippocampus suppress aberrant supragranular sprouting of host mossy fibers. Exp Neurol. 1997;143(2):231-245.
335. Miyamoto O, Itano T, Yamamoto Y, et al. Effect of embryonic hippocampal transplantation in amygdaloid kindled rat. Brain Res. 1993;603(1):143-147.
336. Buzsaki G, Bayardo F, Miles R, Wong RK, Gage FH. The grafted hippocampus: An epileptic focus. Exp Neurol. 1989;105(1):10-22.
337. Buzsaki G, Masliah E, Chen LS, Horvath Z, Terry R, Gage FH. Hippocampal grafts into the intact brain induce epileptic patterns. Brain Res. 1991;554(1-2): 30-37.
338. Fisher LJ, Gage FH. Grafting in the mammalian central nervous system. Physiol Rev. 1993;73(3):583-616.
339. Berkovic SF, Mulley JC, Scheffer IE, Petrou S. Human epilepsies: Interaction of genetic and acquired factors. Trend Neurosci. 2006;29(7):391-397.
340. Raol YH, Lund IV, Bandyopadhyay S, et al. Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci. 2006;26(44):11342-11346.
341. Mazarati A, Wasterlain CG. Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus. Neurosci Lett. 2002;331(2):123-127.
342. Vezzani A, Sperk G. Overexpression of NPY and Y2 receptors in epileptic brain tissue: An endogenous neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides. 2004;38(4):245-252.
343. Lin EJ, Richichi C, Young D, Baer K, Vezzani A, During MJ. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci. 2003;18(7):2087-2092.
344. McCown TJ. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther. 2006;14(1):63-68.
345. Haberman RP, Samulski RJ, McCown TJ. Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. NatMed. 2003;9(8):1076-1080.
346. Richichi C, Lin EJ, Stefanin D, et al. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci. 2004;24(12):3051-3059.
347. Noe F, Pool AH, Nissinen J, et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain. 2008;131(pt 6):1506-1515.
348. Lee KS, Schubert P, Heinemann U. The anticonvulsive action of adenosine: A postsynaptic, dendritic action by a possible endogenous anticonvulsant. Brain Res. 1984;321(1):160-164.
349. Dragunow M, Goddard GV, Laverty R. Is adenosine an endogenous anticonvulsant? Epilepsia. 1985;26(5):480-487.
350. Fedele DE, Li T, Lan JQ, Fredholm BB, Boison D. Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol. 2006;200(1):184-190.
351. Boison D, Huber A, Padrun V, Deglon N, Aebischer P, Mohler H. Seizure suppression by adenosine-releasing cells is independent of seizure frequency. Epilepsia. 2002;43(8):788-796.
352. Huber A, Guttinger M, Mohler H, Boison D. Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci Lett. 2002;329(3):289-292.
353. Guttinger M, Padrun V, Pralong WF, Boison D. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp Neurol. 2005;193(1):53-64.
354. Kanter-Schlifke I, Georgievska B, Kirik D, Kokaia M. Seizure suppression by GDNF gene therapy in animal models of epilepsy. Mol Ther. 2007;15(6): 1106-1113.
355. RaoMS, Hattiangady B, Rai KS, Shetty AK. Strategies for promoting anti-seizure effects of hippocampal fetal cells grafted into the hippocampus of rats exhibiting chronic temporal lobe epilepsy. Neurobiol Dis. 2007;27(2):117-132.
356. Seki T, Matsubayashi H, Amano T, et al. Adenoviral gene transfer of aspartoacylase ameliorates tonic convulsions of spontaneously epileptic rats. Neurochem Int. 2004;45(1):171-178.
357. Klugmann M, Leichtlein CB, Symes CW, Serikawa T, Young D, During MJ. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Mol Ther. 2005;11(5): 745-753.
358. Schiff SJ, Somjen GG. The effects of temperature on synaptic transmission in hippocampal tissue slices. Brain Res. 1985;345(2):279-284.
359. Yang XF, Ouyang Y, Kennedy BR, Rothman SM. Cooling blocks rat hippocampal neurotransmission by a presynaptic mechanism: Observations using 2-photon microscopy. J Physiol. 2005;567(pt 1):215-224.
360. Stefani A. De l action de la temperature sur les centres bulbaires du coeur et des vaisseaux. Arch Ital Biol. 1895;24:424-437.
361. Deganello U. Action de la temperature sur les centres bulbaire inhibiteur du coeur et sur le centre bulbaire vaso-constricteur. Arch Ital Biol. 1900;33:186-188.
362. Brooks V. Study of brain function by local, reversible cooling. Rev Physiol Biochem Pharmacol. 1983;95:1-109.
363. Fay T. Early experiences with local and generalized refrigeration of the human brain. J Neurosurg. 1959;16(3):239-259; discussion 259-260.
364. Hemmen TM, Lyden PD. Induced hypothermia for acute stroke. Stroke. 2007;38(2 suppl):794-799.
365. Rothman SM, Smyth MD, Yang XF, Peterson GP. Focal cooling for epilepsy: An alternative therapy that might actually work. Epilepsy Behav. 2005;7(2): 214-221.
366. Sartorius CJ, Berger MS. Rapid termination of intraoperative stimulation-evoked seizures with application of cold Ringer's lactate to the cortex. Technical note. J Neurosurg. 1998;88(2):349-351.
367. Karkar KM, Garcia PA, Bateman LM, Smyth MD, Barbaro NM, Berger M. Focal
368. Vastola EF, Homan R, Rosen A. Inhibition of focal seizures by moderate hypothermia. A clinical and experimental study. Arch Neurol. 1969;20(4): 430-439.
369. Schmitt FC, Buchheim K, Meierkord H, Holtkamp M. Anticonvulsant properties of hypothermia in experimental status epilepticus. Neurobiol Dis. 2006;23(3):689-696.
370. Hill MW, Wong M, Amarakone A, Rothman SM. Rapid cooling aborts seizurelike activity in rodent hippocampal-entorhinal slices. Epilepsia. 2000;41(10): 1241-1248.
371. Yang XF, Rothman SM. Focal cooling rapidly terminates experimental neocortical seizures. Ann Neurol. 2001;49(6):721-726.
372. Yang XF, Duffy DW, Morley RE, Rothman SM. Neocortical seizure termination by focal cooling: Temperature dependence and automated seizure detection. Epilepsia. 2002;43(3):240-245.
373. Yang XF, Kennedy BR, Lomber SG, Schmidt RE, Rothman SM. Cooling produces minimal neuropathology in neocortex and hippocampus. Neurobiol Dis. 2006;23(3):637-643.
374. Hilderbrand JK, Peterson GP, Rothman SM. Development of a phase change heat spreader to enable focal cooling as a treatment for intractable neocortical epilepsy. Heat Transfer Engineering. 2007;28(4):282-291.
375. Burton JM, Peebles GA, Binder DK, Rothman SM, Smyth MD. Transcortical cooling inhibits hippocampal-kindled seizures in the rat. Epilepsia. 2005;46(12): 1881-1887.
376. Imoto H, Fujii M, Uchiyama J, et al. Use of a Peltier chip with a newly devised local brain-cooling system for neocortical seizures in the rat. Technical note. J Neurosurg. 2006;104(1):150-156.
377. Motamedi GK, Salazar P, Smith EL, et al. Termination of epileptiform activity by cooling in rat hippocampal slice epilepsy models. Epilepsy Res. 2006;70(2-3): 200-210.
378. Rothman SM. The therapeutic potential of focal cooling for neocortical epilepsy. Neurotherapeutics. 2009;6(2):251-257.
379. Bakken HE, Kawasaki H, Oya H, Greenlee JD, Howard MA III. A device for cooling localized regions of human cerebral cortex. Technical note. J Neurosurg. 2003;99(3):604-608.
380. Rezai AR, Finelli D, Nyenhuis JA, et al. Neurostimulation systems for deep brain stimulation: In vitro evaluation of magnetic resonance imaging-related heating at 1.5 tesla. J Magn Reson Imaging. 2002;15(3):241-250.